PharmaNest to Present Six Digital Pathology Abstracts at the International Liver Congress-EASL 2023,
PharmaNest, a leader in high resolution, single-fiber, quantitative Digital Pathology and Artificial Intelligence, showcases the utility and performance of its FibroNest Ph-FCS continuous fibrosis biomarker for the quantification of the severity of fibrosis and prognostics of liver related clinical events in NASH....
Source: pharmiweb.com